Freeline Therapeutics Holdings plc ADR buy Wedbush
Start price
04.10.23
/
50%
€3.21
Target price
04.10.24
€7.61
Performance (%)
0.00%
End price
05.10.24
-
Summary
This prediction is currently being closed. The BUY prediction by Wedbush is currently unchanged from the start price. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Freeline Therapeutics Holdings plc ADR | - | - | - |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % |
Comments by Wedbush for this prediction
In the thread Freeline Therapeutics Holdings plc ADR diskutieren
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock, up previously from $5.00.
Ratings data for FRLN provided by MarketBeat
In the thread Trading Freeline Therapeutics Holdings plc ADR
Die von Wedbush gewählte maximale Laufzeit wurde überschritten